Properdin: A Novel Target for Neuroprotection in Neonatal Hypoxic-Ischemic Brain Injury

Area of Science:

• Neuroscience
• Immunology
• Neonatal Medicine

Background:

• Neonatal hypoxic-ischemic (HI) encephalopathy causes significant mortality and morbidity.
• Infection exacerbates HI brain damage, increasing vulnerability.
• Current treatments like therapeutic hypothermia have limited efficacy, especially in infection-sensitized cases.

Purpose of the Study:

• To investigate the role of properdin in neonatal HI brain damage.
• To evaluate the therapeutic potential of properdin deletion in HI alone and LPS-sensitized HI models.

Main Methods:

• Utilized two mouse models: hypoxic-ischemia (HI) alone and lipopolysaccharide (LPS)-sensitized HI.
• Assessed the effect of global properdin deletion on cell death, microglial activation, and tissue loss.

Main Results:

• Global properdin deletion significantly reduced forebrain cell death and microglial activation in both HI and LPS-sensitized HI models.
• Properdin deletion decreased TUNEL+ cell death and tissue loss at 48 hours post-insult.
• The protective effects were observed in both isolated HI and infection-sensitized HI scenarios.

Conclusions:

• Properdin plays a critical role in neonatal HI brain damage, both alone and when sensitized by infection.
• Targeting properdin represents a promising novel therapeutic strategy for neonatal HI encephalopathy.